Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Gilead Sciences
Incyte Corporation
Acerta Pharma BV
Incyte Corporation
Celgene
Janssen Research & Development, LLC
MEI Pharma, Inc.
AstraZeneca
MEI Pharma, Inc.
BeiGene
BeiGene
Genmab
Altor BioScience
Ipsen
TG Therapeutics, Inc.
Atara Biotherapeutics
Gilead Sciences
Novartis
Pharmacyclics LLC.
Gilead Sciences
Gilead Sciences
Gilead Sciences
Aptevo Therapeutics
INSYS Therapeutics Inc